Cypress Capital’s Abbott ABT Stock Holding History

Cypress Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-915	Closed	-$95.1K	–	82
2024 Q2	$95.1K	Buy	+915	New	+$97K	0.02%	88

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cypress Capital's ABT Position: Q3 2024 in Review

Cypress Capital sold out of Abbott (ABT) in Q3 2024, closing a stake of 915 shares — an estimated $95.1K sold.

Cypress Capital first reported a position in ABT in Q2 2024 and held it in 1 quarter. The position peaked at $95.1K in Q2 2024. 2,897 funds tracked by Wall St. Rank hold ABT as of Q3 2024.

Cypress Capital reported no remaining Abbott position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 915 Abbott shares in Q3 2024, an estimated $95.1K.
Cypress Capital first reported a position in Abbott in Q2 2024 and held it in 1 quarter.
Cypress Capital's Abbott position peaked at $95.1K in Q2 2024.
2,897 funds tracked by Wall St. Rank held Abbott as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.